Chimeric Therapeutics Ltd (CHM)

Currency in AUD
0.01
0.00(0.00%)
Closed·
CHM Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
CHM is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.010.01
52 wk Range
0.000.02
Key Statistics
Bid/Ask
0.01 / 0.01
Prev. Close
-
Open
0.01
Day's Range
0.01-0.01
52 wk Range
0-0.02
Volume
-
Average Volume (3m)
10.86M
1-Year Change
-38.24%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CHM Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock has taken a big hit over the last week

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Strong Sell

Chimeric Therapeutics Ltd Company Profile

Chimeric Therapeutics Limited, a clinical stage cell therapy company, develops and commercializes a range of cell therapies for oncology in Australia. The company develops CHM CDH17 CAR T cell therapy that is in Phase I/II multi-centre clinical trials for the treatment of advanced colorectal cancer, gastric cancer, and intestinal neuroendocrine tumors; and CHM CLTX, a Chlorotoxin CAR T cell therapy, which is in phase Ia/IIb clinical trials for patients with recurrent or progressive Glioblastoma, as well as in preclinical trials for MMP2 expressing solid tumors. It also develops CHM CORE-NK that is in phase Ia/IIb clinical trials for acute myeloid leukaemia/colorectal cancer and acute myeloid cancer, as well as in preclinical trials for blood cancer, solid tumors, MMP2 expressing solid tumors, and CDH17 expressing solid tumors. The company was incorporated in 2020 and is based in Carlton, Australia.

Compare CHM to Peers and Sector

Metrics to compare
CHM
Peers
Sector
Relationship
P/E Ratio
−0.7x−4.5x−0.5x
PEG Ratio
−0.10−0.040.00
Price/Book
2.1x3.4x2.6x
Price / LTM Sales
6.1x14.3x3.3x
Upside (Analyst Target)
-292.3%43.4%
Fair Value Upside
Unlock−1.4%7.1%Unlock

Earnings

Latest Release
Feb 28, 2025
EPS / Forecast
-- / --
Revenue / Forecast
5.55M / --
EPS Revisions
Last 90 days

CHM Income Statement

FAQ

What Stock Exchange Does Chimeric Therapeutics Trade On?

Chimeric Therapeutics is listed and trades on the Sydney Stock Exchange stock exchange.

What Is the Stock Symbol for Chimeric Therapeutics?

The stock symbol for Chimeric Therapeutics is "CHM."

What Is the Chimeric Therapeutics Market Cap?

As of today, Chimeric Therapeutics market cap is 9.76M.

What Is Chimeric Therapeutics's Earnings Per Share (TTM)?

The Chimeric Therapeutics EPS (TTM) is -0.02.

From a Technical Analysis Perspective, Is CHM a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Chimeric Therapeutics Stock Split?

Chimeric Therapeutics has split 1 times.

How Many Employees Does Chimeric Therapeutics Have?

Chimeric Therapeutics has 0 employees.

What is the current trading status of Chimeric Therapeutics (CHM)?

As of 08 Aug 2025, Chimeric Therapeutics (CHM) is trading at a price of 0.01, with a previous close of 0.00. The stock has fluctuated within a day range of 0.01 to 0.01, while its 52-week range spans from 0.00 to 0.02.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.